Synthesis of deuterium-labelled elliptinium and its use in metabolic studies.

The 9-hydroxy-2-(U-2H3) methylellipticinium acetate (elliptinium) was synthesized with an isotopic purity of at least 96%. The structure was confirmed by proton nuclear magnetic resonance and direct probe fast atom bombardment mass spectrometry. A mixture of elliptinium and its deuterated analogue was administered intravenously to rats. In urine, after analysis by liquid chromatography/mass spectrometry (LC/MS), unchanged drug and N-acetylcysteinylelliptinium were found. In bile, after ion-pair extraction and LC/MS, the glutathionylelliptinium was found in addition to the parent drug and the N-acetylcysteine adduct.

[1]  C. Paoletti,et al.  Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137). , 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[2]  C. Paoletti,et al.  Unexpected regiospecific alkylation of the antitumor agent N2-methyl-9-hydroxyellipticinium acetate with N, O or S donors , 1983 .

[3]  W. Vandenheuvel.  Drug Metabolite Identification: Stable Isotope Methods , 1986, Journal of clinical pharmacology.

[4]  F. Cavalli,et al.  Phase II study of 9-hydroxy-2N-methylellipticinium acetate. , 1984, European Journal of Cancer and Clinical Oncology.

[5]  M. Maftouh,et al.  Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates. , 1983, Xenobiotica; the fate of foreign compounds in biological systems.

[6]  M. Maftouh,et al.  Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[7]  C. Paoletti,et al.  A revised structure of the antitumor drug elliptinium--amino(acid) adducts. , 1985, Biochemical and biophysical research communications.

[8]  T. Baillie,et al.  Recent Advances in the Use of Stable Isotopes in Drug Metabolism Research , 1986, Journal of clinical pharmacology.

[9]  J. Droz,et al.  Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study). , 1982, European journal of cancer & clinical oncology.

[10]  J. van der Greef,et al.  Determination of progesterone by liquid chromatography-mass spectrometry using a moving-belt interface and isotope dilution. , 1985, Journal of chromatography.